Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1992-5-15
|
| pubmed:abstractText |
Oxcarbazepine (OXC) is considered to be a promising new antiepileptic drug with similar efficacy and better tolerability compared to carbamazepine (CBZ). However, hyponatremia is supposed to occur even more often than with CBZ. We report on a patient who developed hyponatremic coma under OXC with a serum sodium level of 115 mmol/l, the second published case of OXC-induced hyponatremia with serious clinical adverse effects.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0920-1211
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
67-70
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1563340-Anticonvulsants,
pubmed-meshheading:1563340-Carbamazepine,
pubmed-meshheading:1563340-Coma,
pubmed-meshheading:1563340-Epilepsy,
pubmed-meshheading:1563340-Female,
pubmed-meshheading:1563340-Humans,
pubmed-meshheading:1563340-Hyponatremia,
pubmed-meshheading:1563340-Middle Aged
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Hyponatremic coma under oxcarbazepine therapy.
|
| pubmed:affiliation |
Neurologische Klinik, Ludwig-Maximilians-Universität München, Germany.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|